Post-bariatric Hypoglycemia
📧 Sign up to get email alerts when something new happens for Post-bariatric Hypoglycemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Avexitide for Treatment of Post-Bariatric Hypoglycemia [Phase 3]
Avexitide is in Phase 3 trials for post-bariatric hypoglycemia; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia [Phase 1]
Phase 1 trial evaluating single ascending subcutaneous doses of Exendin 9-39 in individuals with post-bariatric hypoglycemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects [Phase 2]
Phase 2 study evaluating Mizagliflozin for postprandial glucose and insulin in adults with post-bariatric hypoglycemia; results have been po…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 3 [NA]
This clinical trial update notes completion of a study focused on forecasting and preventing post-bariatric hypoglycemia following Roux-en-Y…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating a closed-loop glucagon pump for treatment of post-bariatric hypoglycemia has completed with results posted in 202…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia [Phase 2]
Phase 2 clinical trial evaluating subcutaneous Exendin(9-39) for efficacy, tolerability, and pharmacokinetics in patients with post-bariatri…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery [Phase 4]
Phase 4 clinical trial evaluating pasireotide for reactive hypoglycemia after gastric bypass (post-bariatric hypoglycemia).
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet? [NA]
A completed clinical trial evaluated whether a low-carbohydrate diet reduces postprandial reactive hypoglycemia in patients after Roux-en-Y …